Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 4:27 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1465–1488 of 1,602 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Skin Patch Clear all

Conditions: Skin Irritation
Interventions: Cetaphil Moisturizing Lotion Daily Advance; Other
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 146 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2006
U.S. locations: 1
States / cities: Carrollton, Texas

Conditions: Alopecia Areata
Interventions: Abatacept; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy Adult
Interventions: Collagen-Based Material; Device
Lead sponsor: SerenaGroup, Inc.; Network
Eligibility: 18 Years to 70 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Monroeville, Pennsylvania

Conditions: Smoking, Tobacco Use Cessation
Interventions: MBAT Group Therapy, Nicotine, Group Therapy, Individual Therapy; Behavioral · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 650 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Smoking Cessation
Interventions: Counseling, combination NRT; Behavioral · Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Healthy
Interventions: Metronidazole 0.75% Topical Gel, Metronidazole 0.75% Topical Cream, Transdermal water loss measurement, Electrical Resistance, Skin color measurement, Micropatch application; Drug · Diagnostic Test · Other
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Low Back Pain
Interventions: Etoreat®(Etodolac-Lidocaine Topical Patch), Placebo; Drug
Lead sponsor: MEDRx USA, Inc.; Industry
Eligibility: 14 Years and older
Enrollment: 232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 7
States / cities: Carlsbad, California • Miami, Florida • New York, New York + 4 more

Conditions: PTSD, Smoking
Interventions: Bupropion, nicotine replacement therapy, Smoking cessation counseling, mobile contingency management, Stay Quit Coach; Drug · Other · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Healthy
Interventions: Estradiol Transdermal System Placebo - Alternate Adhesive, Estradiol Transdermal System Placebo - Current Adhesive; Drug
Lead sponsor: Mylan Pharmaceuticals Inc; Industry
Eligibility: 40 Years to 66 Years · Female only
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Intraoperative Bleeding, Hemorrhage, Surgical, Liver Diseases
Interventions: GATT-Patch (currently named ETHIZIA), TachoSil; Device · Drug
Lead sponsor: GATT Technologies BV; Industry
Eligibility: 22 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 6
States / cities: Los Angeles, California • St Louis, Missouri • Newark, New Jersey + 3 more

Conditions: Hernia, Inguinal
Interventions: Biomerix Revive™ (surgical mesh for inguinal hernia repair); Device
Lead sponsor: Biomerix; Industry
Eligibility: 19 Years and older · Male only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Omaha, Nebraska • Houston, Texas

Conditions: Smoking, HIV Infections, AIDS
Interventions: Positively Smoke Free, Standard care; Behavioral
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Smoking Cessation
Interventions: Nicotine Replacement Therapy (NRT), Questionnaire, Counseling, Self-Help Materials; Drug · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cumulative Irritation and Sensitization
Interventions: dATS; Drug
Lead sponsor: Noven Therapeutics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 229 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Jersey City, New Jersey

Conditions: Cardiac Arrhythmia
Interventions: Frontier X Plus chest-strap ECG device, MoMe ARC ambulatory ECG monitor; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 22 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Nevi and Melanomas
Interventions: UV Counseling, UV Photo, Biological Sample; Behavioral · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Psoriasis
Interventions: Shave Biopsy of Psoriasis Lesion; Procedure
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Non-Melanoma Skin Cancer (NMSC)
Interventions: OFDI; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Eczema
Interventions: topical colloidal oatmeal formulation with a modified plant oil, topical colloidal oatmeal formulation; Other
Lead sponsor: GlycosBio, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Parkinson Disease, Parkinson Disease Dementia
Interventions: Rivastigmine transdermal patch; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Nicotine Addiction, Panic Attack
Interventions: d-cycloserine, Pill Placebo, Nicotine replacement therapy, Panic and Smoking Reduction Treatment; Drug · Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Prevention of Travelers' Diarrhea
Interventions: heat-labile enterotoxin of E. coli (LT); Biological
Lead sponsor: Intercell USA, Inc.; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 3
States / cities: Little Rock, Arkansas • South Miami, Florida • Salt Lake City, Utah

Conditions: Postoperative Pain, Obstetric Pain, Opioid Use
Interventions: Lidocaine patch, Placebo patch; Drug · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 52 Years · Female only
Enrollment: 93 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Smoking
Interventions: Financial counseling, Nicotine Replacement Therapy Agent - Patches, Nicotine Replacement Therapy Agent - Lozenges, Nicotine Replacement Therapy Agent - Gum; Other · Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 100 Years
Enrollment: 602 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion

An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata

Human Repeat Insult Patch Test to Evaluate Skin Irritation and Sensitization in Healthy Volunteers

Group Therapy for Nicotine Dependence: Mindfulness and Smoking

Nicotine Replacement Therapy (NRT) Sampling and Selection to Increase Medication Adherence

Pharmacokinetics of Transdermal Metronidazole

Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain

Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD

Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System

GATT-Patch Versus TachoSil in Liver Surgery

Study of Surgical Mesh for Inguinal Hernia Repair

A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs)

Determinants of Smoking Cessation Among Latinos

Irritation and Sensitization Study of d-Amphetamine Transdermal System

Feasibility and Usability of a Chest-Strap Ambulatory ECG Monitor in Active Individuals in Comparison With a Traditional Ambulatory ECG Patch Monitor (MoMe ARC)

Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma

Role of Chemokine and Chemokine Receptor in Psoriasis

Optical Frequency Domain Imaging for Non-melanoma Skin Cancers

Assessment of the Effects on the Skin Microbiome of Amending an Over-the-counter Eczema Product With Activated Oil (AO)

Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease

Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine

LT Vaccine Patch Self-Administration Study

Lidocaine Patches After Cesarean Section

Integrating Financial Coaching and Smoking Cessation Coaching